FIGS, Inc. (FIGS)
| Market Cap | 2.00B +180.6% |
| Revenue (ttm) | 666.10M +18.7% |
| Net Income | 40.64M +3,335.3% |
| EPS | 0.21 +2,918.1% |
| Shares Out | 167.05M |
| PE Ratio | 56.06 |
| Forward PE | 42.62 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,804,640 |
| Open | 11.45 |
| Previous Close | 11.28 |
| Day's Range | 11.20 - 12.08 |
| 52-Week Range | 4.98 - 17.48 |
| Beta | 0.99 |
| Analysts | Buy |
| Price Target | 17.63 (+47.41%) |
| Earnings Date | May 7, 2026 |
About FIGS
FIGS, Inc., together with its subsidiary, FIGS Canada, Inc., operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. The company designs and sells scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel. It also offers sports apparel, performance leggings and tops, super-soft pima cotton tops, vests, fleeces, and jackets; and necessities comprising scrub caps, lanyards, badge reels, bags, baseball caps... [Read more]
Financial Performance
In 2025, FIGS, Inc.'s revenue was $631.10 million, an increase of 13.60% compared to the previous year's $555.56 million. Earnings were $34.25 million, an increase of 1159.19%.
Financial StatementsAnalyst Summary
According to 9 analysts, the average rating for FIGS stock is "Buy." The 12-month stock price target is $17.63, which is an increase of 47.41% from the latest price.
News
FIGS, Inc. Transcript: Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference
Sales growth has re-accelerated across all categories and regions, driven by product innovation and marketing. Profitability is improving despite tariff headwinds, with ongoing investments in B2B, retail expansion, and product layering. Strong cash flow supports both growth and shareholder returns.
FIGS, Inc. Transcript: AGM 2026
The meeting, held virtually, covered director elections, auditor ratification, and executive compensation approval. All proposals passed, with final results to be filed on Form 8-K. No shareholder questions were received.
FIGS Announces Participation in the Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced that Trina Spe...
FIGS, Inc. Earnings Call Transcript: Q1 2026
Net revenues rose 28% year-over-year to $159.9 million, with active customers surpassing three million and strong growth across all segments. Full-year guidance was raised, reflecting confidence in continued momentum despite tariff and freight headwinds.
FIGS, Inc. Slides: Q1 2026
FIGS, Inc. has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 7, 2026.
FIGS, Inc. Earnings release: Q1 2026
FIGS, Inc. released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.
FIGS, Inc. Quarterly report: Q1 2026
FIGS, Inc. has published its Q1 2026 quarterly earnings report on May 7, 2026.
FIGS Releases First Quarter 2026 Financial Results
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS) (the “Company”), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released...
FIGS and Noah Wyle Launch Long-Term Partnership to Advocate for the Healthcare Workforce and Reduce Medical Debt
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand, today announced a long-term partnership with Noah Wyle, Emmy-award winning executive produc...
Figs price target raised to $19 from $17 at KeyBanc
KeyBanc raised the firm’s price target on Figs (FIGS) to $19 from $17 to reflect recent share momentum post-Q4 earnings and on maintained conviction that improving fundamentals are more structural…
FIGS, Inc. Proxy statement: Proxy filing
FIGS, Inc. filed a proxy statement on April 23, 2026, providing details for shareholder voting and corporate governance matters.
FIGS, Inc. Proxy statement: Proxy filing
FIGS, Inc. filed a proxy statement on April 23, 2026, providing details for shareholder voting and corporate governance matters.
Figs price target raised to $18 from $15.50 at Roth Capital
Roth Capital analyst Matt Koranda raised the firm’s price target on Figs (FIGS) to $18 from $15.50 and keeps a Buy rating on the shares ahead of its Q1 results.
FIGS Announces Date of First Quarter 2026 Earnings Release, Conference Call and Webcast
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced it will releas...
Figs price target raised to $15 from $8 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Figs (FIGS) to $15 from $8 and keeps an Equal Weight rating on the shares. Fundamentals have meaningfully improved on sharper execution,…
Oppenheimer upgrades Figs to Outperform on ‘sustained recovery’
Oppenheimer analyst Brian Nagel upgraded Figs (FIGS) to Outperform from Perform with a $22 price target The company is positioned for a “sustained recovery,” the analyst tells investors in a…
Figs upgraded to Outperform from Perform at Oppenheimer
Oppenheimer analyst Brian Nagel upgraded Figs (FIGS) to Outperform from Perform with a $22 price target
FIGS put volume heavy and directionally bearish
Bearish flow noted in FIGS (FIGS) with 1,325 puts trading, or 11x expected. Most active are Apr-26 12.5 puts and Oct-26 12.5 puts, with total volume in those strikes near…
FIGS-Developed Healthcare is Human Act Introduced in Congress to Provide Federal Tax Credit for Healthcare Professionals
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand, announced the introduction of the Healthcare is Human Act, a milestone bipartisan bill spon...
Figs price target raised to $17 from $15 at Telsey Advisory
Telsey Advisory raised the firm’s price target on Figs (FIGS) to $17 from $15 and keeps a Market Perform rating on the shares. The firm notes international is a key…
FIGS put volume heavy and directionally bearish
Bearish flow noted in FIGS (FIGS) with 1,021 puts trading, or 9x expected. Most active are Apr-26 15 puts and Mar-26 17.5 puts, with total volume in those strikes near…
FIGS, Inc. Transcript: 47th Annual Raymond James Institutional Investor Conference
Premium healthcare apparel brand reported 33% Q4 revenue growth, driven by product innovation, viral marketing, and global expansion. Despite tariff headwinds, expects margin improvement and continued investment in omni-channel and B2B growth.
Figs price target raised to $20 from $15 at BTIG
BTIG raised the firm’s price target on Figs (FIGS) to $20 from $15 and keeps a Buy rating on the shares after its Q4 earnings beat, saying the stock has…